Overview
Indications
® ENDOMETRIN(progesterone) is indicated to support embryo implantation and early pregnancy by supplementation of corpus luteal function as part of an Assisted Reproductive Technology (ART) treatment program for infertile women.
Contraindications
When this intervention should not be used
ENDOMETRIN is contraindicated in individuals with any of the following conditions: see Description (11) Previous allergic reactions to progesterone or any of the ingredients of ENDOMETRIN [] Undiagnosed vaginal bleeding Known missed abortion or ectopic pregnancy Liver disease Known or suspected mali
Indications & Related Conditions
Conditions associated via SNOMED clinical relationships
Administration & Protocol
Dosing, route, and treatment protocol
Detailed dosage and administration information is available in the full FDA drug label.
View full prescribing information on DailyMedMonitoring & Follow-Up
Biomarkers relevant to this intervention via related conditions
Clinical Trials
4 trials linked to this intervention
Recent Trials
A Study Comparing Mirena and Systemic Progestin for Endometrial Hyperplasia
Apoptotic Signaling Pathways in Rats With Endometrial Hyperplasia
Vaginal Estrogens Comparative Trial on Pelvic Organ Prolapse Patients
A Study to Estimate Early Clinical Efficacy Signals of GLP-1 Agonist Administration in Conjunction With Levonorgestrel Intrauterine Device in Obese Patients With Endometrioid Intraepithelial Neoplasia
Research Evidence
Published studies and systematic reviews
Research data from MEDLINE/PubMed
Benefits & Expected Outcomes
Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.
Risks & Side Effects
Adverse reaction and safety data for this drug is sourced from the FDA-approved label.
View adverse reactions & drug interactions on DailyMedRelated Symptoms
Symptoms associated with conditions this intervention addresses
No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.
Alternatives & Comparisons
Alternative treatments, comparison data, and clinical decision support are pending physician authorship.
This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.
Do not start, stop, or change any treatment without consulting your healthcare provider.
Specialists
Providers who commonly manage this intervention
Quick Facts
- Type
- Substance / Medication
- Fully Specified Name
- Progesterone (substance)
- SNOMED CT
- 16683002
- UMLS CUI
- C0033308
- RxNorm CUI
- 8727
- Labeler
- Ferring Pharmaceuticals Inc.
Clinical Data
This intervention maps to 8 entities in the Ltrl knowledge graph.
Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.